Company / Working Capital
Pulmonx Corp Working Capital History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$81.6M
FY2025
5-year range
$81.6M / $190.5M
FY2021-FY2025
Trend
-27.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has declined for 5 consecutive years, from $237M in FY2020 to $82M in FY2025.
Based on SEC 10-K filings.
$82M in FY2025 with a 5-year CAGR of -19.2%.
Declined from $127M to $82M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -18.4%
- 5-Year CAGR
- -19.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- Pulmonx Corp's working capital has declined for 5 consecutive years.
- 5-year CAGR of -19.2%, indicating a declining trend.
- In FY2025, working capital decreased 27.0% year-over-year.
- Peak working capital was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $81.6M | -27.0% |
| FY2024 | $111.8M | -12.1% |
| FY2023 | $127.3M | -15.4% |
| FY2022 | $150.5M | -21.0% |
| FY2021 | $190.5M | -19.8% |
| FY2020 | $237.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026